Standard BioTools
LAB
LAB
144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
18.23% less ownership
Funds ownership: 91.46% → 73.23% (-18%)
33% less capital invested
Capital invested by funds: $719M → $480M (-$239M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
144
Holding in Top 10
2
Calls
$1.26M
Puts
$110K
Top Buyers
| 1 | +$28.9M | |
| 2 | +$9.41M | |
| 3 | +$7.24M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.26M |
Top Sellers
| 1 | -$20M | |
| 2 | -$14.4M | |
| 3 | -$6.81M | |
| 4 |
Goldman Sachs
New York
|
-$4.67M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$4.53M |